ILO Home
Go to the home page
Site map | Contact us Franšais | Espa˝ol
view in a printer-friendly format »

Viral diseases (other than aids) - 2 entries found

Your search criteria are

  • Country / Organization: USA
  • Viral diseases (other than aids)

2001

CIS 01-1309
Department of Labor - Occupational Safety and Health Administration (OSHA)
Occupational Exposure to Bloodborne Pathogens; Needlestick and Other Sharps Injuries: Final Rule [USA]
This is a revision of the Bloodborne Pathogens standard (for 1991 original, see CIS 93-371) in conformity with the requirements of the Needlestick Safety and Prevention Act. New examples have been included in the definition of engineering controls, along with two new definitions (needleless systems and sharps with engineered sharps injury protections). In addition, employers who are required to establish an Exposure Control Plan must document how the Plan is implemented. Certain employers are also required to establish and maintain a log of percutaneous injuries from contaminated sharps.
Federal Register, 18 Jan. 2001, Vol.66, No.12, p.5318-5325.
http://www.osha.gov/FedReg_osha_data/FED20010118A.html [in English]
http://www.osha.gov/FedReg_osha_pdf/FED20010118A.pdf [in English]

1991

CIS 93-371
Department of Labor - Occupational Safety and Health Administration (OSHA)
Occupational Exposure to Bloodborne Pathogens: Final Rule [USA]
This standard (effective 6 Mar. 1992), aimed at eliminating or minimising occupational exposure to bloodborne pathogens (particularly Hepatitis B Virus (HBV) and Human Immunodeficiency Virus (HIV)), concerns: definitions; exposure controls; methods of compliance (engineering and work practice controls, personal protective equipment, housekeeping); HIV and HBV research laboratories and production facilities; Hepatitis B vaccination and post-exposure evaluation and follow-up; communication of hazards to employees (labels and signs, information and training); recordkeeping. The introduction to the standard includes a very detailed discussion of: events leading to the standard; health effects of exposure to bloodborne pathogens (epidemiology and symptoms of Hepatitis B and AIDS; other bloodborne pathogens: syphilis, malaria, babesiosis, brucellosis, leptospirosis, arboviral infections, relapsing fever, Creutzfeldt-Jacob disease, human T-lymphotropic virus type I, viral haemorrhagic fever); quantitative risk assessment (principally among health-care workers); significance of risk; regulatory impact/flexibility analysis; environmental impact.
Federal Register, 6 Dec. 1991, Vol.56, No.235, p.64003-64182. Illus.